Past Events
September 28, 2022 at 8:00 AM EDT
March 16, 2022 at 8:50 AM EDT
CEO Dr. James McArthur and VP of Clinical Science Dr. Jane Larkindale to present abstract, “Unlocking the potential of oligonucleotide therapeutics for Duchenne muscular dystrophy through enhanced delivery”
February 28, 2022 at 1:00 PM EST
PepGen attended and sponsored event
February 17 - February 20, 2022
CEO Dr. James McArthur presented on PepGen’s EDO platform
February 10, 2022 at 10:00 AM EST
CEO Dr. James McArthur joined other experts in a panel discussion